Printer-friendly versionPrinter-friendly version

2019 - Reference list of hepatitis publications of the VHPB board members

Persistence of HBsAg‐specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults

Pierre Van Damme, Marc Dionne, Geert Leroux‐Roels, Olivier Van Der Meeren, Emmanuel Di Paolo, Bruno Salaun, Pemmaraju Surya Kiran, Nicolas Folschweiller

J Viral Hepat. 2019;00:1–10.


Psychosocial and Neurocognitive Factors Associated With Hepatitis C - Implications for Future Health and Wellbeing.

Barreira DP, Marinho RT, Bicho M, Fialho R, Ouakinin SRS.

Front Psychol. 2019 Jan 9;9:2666. doi: 10.3389/fpsyg.2018.02666


Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.

Litzroth A, Suin V, Wyndham-Thomas C, Quoilin S, Muyldermans G, Vanwolleghem T, Kabamba-Mukadi B, Verburgh V, Jacques M, Van Gucht S, Hutse V.

BMC Public Health. 2019 Jan 8;19(1):39. doi: 10.1186/s12889-018-6347-z.


Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohort.

Brichler S, Nahon P, Zoulim F, Layese R, Bourcier V, Audureau E, Sutton A, Letouze E, Cagnot C, Marcellin P, Guyader D, Roulot D, Pol S, de Ledinghen V, Zarski JP, Calès P, Tran A, Peron JM, Mallat A, Riachi G, Grange JD, Blanc JF, Bacq Y, Ouzan D, Bronowicki JP, Mathurin P, Larrey D, Alric L, Attali P, Serfaty L, Pilette C, Bourlière M, Thabut D, Silvain C, Wartelle C, Zucman D, Christidis C, Roudot-Thoraval F, Ganne-Carrie N; ANRS CO12 CirVir study group.

J Viral Hepat. 2019 Mar;26(3):384-396. doi: 10.1111/jvh.13029. Epub 2019 Jan 16.


Effectiveness and impact of the hepatitis B vaccination program in preadolescents in Catalonia 21 years after its introduction.

Borràs E, Urbiztondo L, Carmona G, Jané M, Barrabeig I, Sala MR, Balañà J, Company M, Parrón I, Godoy P, Rius C, Soldevila N, Cabezas C, Domínguez Àthe Working Group for the Study of Hepatitis B in Catalonia.

Vaccine. 2019 Feb 21;37(9):1137-1141. doi: 10.1016/j.vaccine.2019.01.024. Epub 2019 Jan 29.


Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.

Thabut D, Bureau C, Layese R, Bourcier V, Hammouche M, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Goria O, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Blanc JF, Abergel A, Serfaty L, Mallat A, Grangé JD, Attali P, Bacq Y, Wartelle-Bladou C, Dao T, Pilette C, Silvain C, Christidis C, Capron D, Bernard-Chabert B, Hillaire S, Di Martino V, Sutton A, Audureau E, Roudot-Thoraval F, Nahon P; ANRS CO12 CirVir group.

Gastroenterology. 2019 Mar;156(4):997-1009.e5. doi: 10.1053/j.gastro.2018.11.053. Epub 2019 Feb 13.


Genetically similar hepatitis E virus strains infect both humans and wild boars in the Barcelona area, Spain, and Sweden.

Wang H, Castillo-Contreras R, Saguti F, López-Olvera JR, Karlsson M, Mentaberre G, Lindh M, Serra-Cobo J, Norder H.

Transbound Emerg Dis. 2019 Mar;66(2):978-985. doi: 10.1111/tbed.13115. Epub 2019 Feb 14. PubMed PMID: 30597741.


High Frequency of Either Altered Pre-Core StartCodon or Weakened Kozak Sequence in the CorePromoter Region in Hepatitis B Virus A1 Strainsfrom Rwanda.

Norder H, Twagirumugabe T, Said J, Tian Y, Tang KW, Lindh M.

Genes (Basel). 2019 Feb 26;10(3). pii: E182. doi:  10.3390/genes10030182. PubMed PMID: 30813638; PubMed Central PMCID: PMC6471190.


Comparative purification and characterization of hepatitis B virus-like particles produced by recombinant vaccinia viruses in human hepatoma cells and human primary hepatocytes.

Reuschel E, Jilg W, Seelbach-Goebel B, Deml L.

PLoS One. 2019 Feb 22;14(2):e0212800. doi: 10.1371/journal.pone.0212800. eCollection 2019.


Immunization against Hepatitis A. Shouval D.

In Enteric hepatitis viruses; Edts SM Lemon and CM Walker pp361-375. Cold Spring Harb Perspect Med. 2018


8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive non-cirrhotic HCV genotype 4 infected patients (HEPNED-001 study).

Boerekamps A, Vanwolleghem T, van der Valk M, van den Berk GE, van Kasteren M, Posthouwer D, Dofferhoff ASM, van Hoek B, Ramsoekh D, Koopsen J, Schinkel J, Florence E, Arends JE, Rijnders BJ.

J Hepatol. 2019 Mar;70(3):554-557. doi: 10.1016/j.jhep.2018.10.032. Epub 2018 Dec 5. No abstract available.


Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients.

Salmon-Ceron D, Nahon P, Layese R, Bourcier V, Sogni P, Bani-Sadr F, Audureau E, Merchadou L, Dabis F, Wittkop L, Roudot-Thoraval F; ANRS CO12 CirVir and ANRS CO13 HEPAVIH study groups.

Hepatology. 2019 Sep;70(3):939-954. doi: 10.1002/hep.30400. Epub 2019 Mar 15.


Hepatitis E virus strains infecting Swedish domestic pigs are unique for each pig farm and remain in the farm for at least 2 years.

Wang H, Karlsson M, Lindberg M, Nyström K, Norder H.

Transbound Emerg Dis. 2019 May;66(3):1314-1323. doi: 10.1111/tbed.13153. Epub 2019 Mar 19. PubMed PMID: 30784199.


HEVnet: a One Health, collaborative, interdisciplinary network and sequence data repository for enhanced hepatitis E virus molecular typing, characterisation and epidemiological investigations.

Mulder AC, Kroneman A, Franz E, Vennema H, Tulen AD, Takkinen J, Hofhuis A, Adlhoch C; Members Of HEVnet.

Euro Surveill. 2019 Mar;24(10). doi: 10.2807/1560-7917.ES.2019.24.10.1800407. PubMed PMID: 30862334; PubMed Central PMCID: PMC6415499.


Estimated cost of comprehensive syringe service program in the United States.

Teshale EH, Asher A, Aslam MV, Augustine R, Duncan E, Rose-Wood A, Ward J, Mermin J, Owusu-Edusei K, Dietz PM.

PLoS One. 2019 Apr 26;14(4):e0216205. doi: 10.1371/journal.pone.0216205. eCollection 2019.


Changes to the national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs between 2013 and 2016: a cross-sectional survey of 34 European countries.

Maticic M, Zorman JV, Gregorcic S, Schatz E, Lazarus JV.

Harm Reduct J. 2019 May 9;16(1):32. doi: 10.1186/s12954-019-0303-9.


Isolation of Subtype 3c, 3e and 3f-Like Hepatitis E Virus Strains Stably Replicating to High Viral Loads in an Optimized Cell Culture System.

Schemmerer M, Johne R, Erl M, Jilg W, Wenzel JJ.

Viruses. 2019 May 28;11(6). pii: E483. doi: 10.3390/v11060483


Scaling-up Hepatitis C Prevention and Treatment Interventions for Achieving Elimination in the United States - a Rural and Urban Comparison.

Fraser H, Vellozzi C, Hoerger TJ, Evans JL, Kral AH, Havens J, Young AM, Stone J, Handanagic S, Hariri S, Barbosa C, Hickman M, Leib A, Martin NK, Nerlander L, Raymond HF, Page K, Zibbell J, Ward JW, Vickerman P.

Am J Epidemiol. 2019 May 31. pii: kwz097. doi: 10.1093/aje/kwz097. [Epub ahead of print]


Sustained off-treatment viral control is associated with high hepatitis B surface antigen seroclearance rates in Caucasian patients with nucleos(t)ide analogue-induced HBeAg seroconversion.

Van Hees S, Chi H, Hansen B, Bourgeois S, Van Vlierberghe H, Sersté T, Francque S, Wong D, Sprengers D, Moreno C, Nevens F, Janssen HLA, Vanwolleghem T.

J Viral Hepat. 2019 Jun;26(6):766-769. doi: 10.1111/jvh.13084. Epub 2019 Mar 14. No abstract available.


The new Xpert HCV viral load real-time PCR assay accurately quantifies hepatitis C virus RNA in serum and whole-blood specimens.

Wlassow M, Poiteau L, Roudot-Thoraval F, Rosa I, Soulier A, Hézode C, Ortonne V, Pawlotsky JM, Chevaliez S.

J Clin Virol. 2019 Aug;117:80-84. doi: 10.1016/j.jcv.2019.06.007. Epub 2019 Jun 22.


Hepatitis A and E virus infections have different epidemiological patterns in Rwanda.

Twagirumugabe T, Saguti F, Habarurema S, Gahutu JB, Bergström T, Norder H.

Int J Infect Dis. 2019 Sep;86:12-14. doi: 10.1016/j.ijid.2019.06.019. Epub 2019 Jun 22. PubMed PMID: 31238154.


Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review.

Mason LM, Duffell E, Veldhuijzen IK, Petriti U, Bunge EM, Tavoschi L.

Euro Surveill. 2019 Jul;24(30).


Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: A systematic review.

Mason LMK, Veldhuijzen IK, Duffell E, van Ahee A, Bunge EM, Amato-Gauci AJ, Tavoschi L.

J Viral Hepat. 2019 Jul 22.  


Caucasian Ethnicity, but Not Treatment Cessation is Associated with HBsAg Loss Following Nucleos(t)ide Analogue-Induced HBeAg Seroconversion.

Van Hees S, Chi H, Hansen B, Bourgeois S, Van Vlierberghe H, Sersté T, Francque S, Wong D, Sprengers D, Moreno C, Nevens F, Janssen H, Vanwolleghem T.

Viruses. 2019 Jul 26;11(8). pii: E687. doi: 10.3390/v11080687.


Cost-effectiveness of scaling-up HCV prevention and treatment in the United States for people who inject drugs.

Barbosa C, Fraser H, Hoerger TJ, Leib A, Havens JR, Young A, Kral A, Page K, Evans J, Zibbell J, Hariri S, Vellozzi C, Nerlander L, Ward JW, Vickerman P.

Addiction. 2019 Jul 15. doi: 10.1111/add.14731. [Epub ahead of print]


Hepatitis B and C among healthcare workers and patient groups at increased risk of iatrogenic transmission in the European Union/European Economic Area.

Tavoschi L, Mason L, Petriti U, Bunge E, Veldhuijzen I, Duffell E.

J Hosp Infect. 2019 Aug;102(4):359-368.  


Biobanking for Viral Hepatitis Research.

Ho E, Van Hees S, Goethals S, Smits E, Huizing M, Francque S, De Winter B, Michielsen P, Vanwolleghem T.

Front Med (Lausanne). 2019 Aug 20;6:183. doi: 10.3389/fmed.2019.00183. eCollection 2019.


Cascade of care for migrants tested Hepatitis C antibodies positive in France through a systematic screening programme: The PRECAVIR study.

Rosa-Hezode I, Chousterman M, Costes L, Labourdette C, Elghozi B, Krastinova E, Roudot-Thoraval F.

Viral Hepat. 2019 Aug 21. doi: 10.1111/jvh.13192. [Epub ahead of print]


Hepatitis E virus genotype 3 is associated with gallstone-related disease.

Karlsson M, Norder H, Bergström M, Park PO, Karlsson M, Wejstål R, Alsiö Å, Rosemar A, Lagging M, Mellgren Å.

Scand J Gastroenterol. 2019 Sep 25:1-5. doi: 10.1080/00365521.2019.1666163. [Epub ahead of print]


Hepatitis E virus genotype 3 strains and a plethora of other viruses detected in raw and still in tap water.

Wang H, Kjellberg I, Sikora P, Rydberg H, Lindh M, Bergstedt O, Norder H.

Water Res. 2019 Sep 30;168:115141. doi: 10.1016/j.watres.2019.115141. [Epub ahead of print]


State of viral hepatitis care in 16 countries of Central and Eastern European Region.

Chkhartishvili N, Holban T, Simonović Babić J, Alexiev I, Matičič M, Kowalska J, Horban A; ECEE Network Group.

Cent Eur J Public Health. 2019 Sep;27(3):212-216. doi: 10.21101/cejph.a5486.


Deaths Associated with Hepatitis C Virus Infection among Residents in 50 States and the District of Columbia, 2016-2017.

Ly KN, Miniño AM, Liu SJ, Roberts H, Hughes EM, Ward JW, Jiles RB.  

Clin Infect Dis. 2019 Oct 5. pii: ciz976. doi: 10.1093/cid/ciz976.


Hepatitis C Pretreatment Profile and Gender Differences: Cognition and Disease Severity Effects.

Barreira DP, Marinho RT, Bicho M, Flores I, Fialho R, Ouakinin S.

Front Psychol. 2019 Oct 15;10:2317. doi: 10.3389/fpsyg.2019.02317.


We know DAAs work, so now what? Simplifying models of care to enhance the hepatitis C cascade.

Lazarus JV, Pericàs JM, Picchio C, Cernosa J, Hoekstra M, Luhmann N, Maticic M, Read P, Robinson EM, Dillon JF.

J Intern Med. 2019 Nov;286(5):503-525. doi: 10.1111/joim.12972. Epub 2019 Oct 4.


Hepatitis E Virus Shows More Genomic Alterations in Cell Culture than In Vivo.

Sari G, van de Garde MDB, van Schoonhoven A, Voermans JJC, van der Eijk AA, de Man RA, Boonstra A, Vanwolleghem T, Pas SD. Pathogens.

2019 Nov 22;8(4). pii: E255. doi: 10.3390/pathogens8040255.


Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines.

Bonanni P, Boccalini S, Bechini A, Varone O, Matteo G, Sandri F, Gabutti G.

Hum Vaccin Immunother. 2019 Dec 10:1-9. doi: 10.1080/21645515.2019.1688032.


Prevalence, incidence and residual risk of transfusion-transmitted hepatitis B virus infection in Italy from 2009 to 2018.

Velati C, Romanò L, Pati I, Marano G, Piccinini V, Catalano L, Pupella S, Vaglio S, Veropalumbo E, Masiello F, Pisani G, Grazzini G, Zanetti A, Liumbruno GM.

Blood Transfus. 2019 Nov;17(6):409-417. doi: 10.2450/2019.0245-19. Epub 2019 Dec 11.


Non-invasive fibrosis tests to predict complications in compensated post-hepatitis C cirrhosis.

Zarski JP, David-Tchouda S, Trocme C, Margier J, Vilotitch A, Hilleret MN, Cagnot C, Boursier V, Ziol M, Sutton A, Layese R, Audureau E, Roudot-Thoraval F, Nahon P.

Clin Res Hepatol Gastroenterol. 2019 Dec 12. pii: S2210-7401(19)30256-6. doi: 10.1016/j.clinre.2019.11.005.


Prevention of hepatitis A. Daniel Shouval.

In: Viral Hepatitis in Children 2019. Prevention and management. Edt. Mei-Hwei Chang and Kathleen B Schwartz. PP 91-102 Springer


The immunological basis for immunization series: module 18: Hepatitis A. Immunization, Vaccines and Biologicals.

Shouval D and Van Damme P.

Geneve, World Health Organization 2019, https://www.who.int/immunization/documents/ISBN_978-92-51632-7/en/